Prognostic predictors of immunotherapy in patients with small cell lung cancer / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 179-182, 2023.
Artículo
en Chino
| WPRIM
| ID: wpr-989541
ABSTRACT
The emergence of immune checkpoint inhibitors holds new promise for patients with small cell lung cancer. Studies have found that PD-L1 expression, tumor mutation burden, genomic characteristics, peripheral blood parameters and other indicators can be used as prognostic predictors in patients with small cell lung cancer receiving immunotherapy. Further exploration and evaluation of relevant predictors can provide a reference for screening patients with potential benefits of immunotherapy.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of International Oncology
Año:
2023
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS